Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FGF-2 for Chronic Tympanic Membrane Perforations
NCT02307916Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in tympanic membrane perforation comparing FGF-2 with Placebo (2 arms). Primary endpoint: Number of Patients With Tympanic Membrane Closure Following Treatment at 60 days. Started Oct 2016; status: completed.
02
Drugs
trafermin
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on NCT02307916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307916.